Search Results - "Cox, M.J."

Refine Results
  1. 1

    Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older by Dunkle, Lisa M, Izikson, Ruvim, Patriarca, Peter, Goldenthal, Karen L, Muse, Derek, Callahan, Janice, Cox, Manon M.J

    Published in The New England journal of medicine (22-06-2017)
    “…Influenza epidemics cause substantial morbidity. The seasonal vaccine, an important control measure, is not completely efficacious. This trial assessed the…”
    Get full text
    Journal Article
  2. 2

    Recombinant protein vaccines produced in insect cells by Cox, Manon M.J

    Published in Vaccine (27-02-2012)
    “…Highlights ► BEVS has matured into a commercial manufacturing technology. ► A broad range of vaccines can be produced in a universal “plug and play” process. ►…”
    Get full text
    Journal Article
  3. 3

    Formal to informal learning with IT: research challenges and issues for e-learning by Cox, M.J.

    Published in Journal of computer assisted learning (01-02-2013)
    “…For the purpose of clarity and consistency, the term e‐learning is used throughout the paper to refer to technology‐enhanced learning and information…”
    Get full text
    Journal Article
  4. 4

    Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant by Gordon, David L, Sajkov, Dimitar, Woodman, Richard J, Honda-Okubo, Yoshikazu, Cox, Manon M.J, Heinzel, Susanne, Petrovsky, Nikolai

    Published in Vaccine (03-08-2012)
    “…Highlights ► Randomized clinical trial of a novel adjuvanted H1N1/2009 pandemic influenza vaccine. ► Reports first pandemic use of a vaccine based on…”
    Get full text
    Journal Article
  5. 5

    Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process by Buckland, Barry, Boulanger, Robert, Fino, Mireli, Srivastava, Indresh, Holtz, Kathy, Khramtsov, Nikolai, McPherson, Clifton, Meghrous, Jamal, Kubera, Paul, Cox, Manon M.J

    Published in Vaccine (22-09-2014)
    “…Highlights • Successful fivefold scale-up to 2500 L scale of first FDA licensed recombinant influenza vaccine. • FDA licensed process is reproducible for a…”
    Get full text
    Journal Article
  6. 6

    Development and Validation of a Hopkinson Bar for Hazardous Materials by Quinn, R.M., Zhang, L.H., Cox, M.J., Townsend, D., Cartwright, T., Aldrich-Smith, G., Hooper, P.A., Dear, J.P.

    Published in Experimental mechanics (01-11-2020)
    “…Background There are a variety of approaches that can be employed for Hopkinson bar compression testing and there is no standard procedure. Objectives A…”
    Get full text
    Journal Article
  7. 7

    FluBlok, a next generation influenza vaccine manufactured in insect cells by Cox, Manon M.J., Hollister, Jason R.

    Published in Biologicals (01-06-2009)
    “…FluBlok, a recombinant trivalent hemagglutinin (rHA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive…”
    Get full text
    Journal Article
  8. 8

    The effect of impurity inclusions on the pitting corrosion behaviour of beryllium by Punni, J.S., Cox, M.J.

    Published in Corrosion science (01-08-2010)
    “…An electrochemical polarisation study has been conducted to determine the effect of impurity inclusions on the pitting corrosion behaviour of beryllium. Three…”
    Get full text
    Journal Article
  9. 9

    Expression and purification of an influenza hemagglutinin—one step closer to a recombinant protein-based influenza vaccine by Wang, Keyang, Holtz, Kathleen M., Anderson, Karl, Chubet, Richard, Mahmoud, Wafaa, Cox, Manon M.J.

    Published in Vaccine (15-03-2006)
    “…Numerous human infections with avian influenza viruses in Asia in recent years have raised the concern that the next influenza pandemic is imminent. The most…”
    Get full text
    Journal Article
  10. 10

    FluBlok, a recombinant hemagglutinin influenza vaccine by Cox, Manon M.J., Patriarca, Peter A., Treanor, John

    Published in Influenza and other respiratory viruses (01-11-2008)
    “…FluBlok, a recombinant trivalent hemagglutinin (HA) vaccine produced in insect cell culture using the baculovirus expression system, provides an attractive…”
    Get full text
    Journal Article
  11. 11

    A fast track influenza virus vaccine produced in insect cells by Cox, Manon M.J., Hashimoto, Yoshifumi

    Published in Journal of invertebrate pathology (01-07-2011)
    “…[Display omitted] ► A recombinant hemagglutinin vaccine (FluBlok) is produced in insect cells. ► Characterization of cell substrate revealed no evidence of…”
    Get full text
    Journal Article
  12. 12

    Plant species responses along a grazing disturbance gradient in Australian grassland by Fensham, R.J, Holman, J.E, Cox, M.J

    Published in Journal of vegetation science (01-02-1999)
    “…Floristic data from paired roadside-paddock analyses from grassland in central Queensland, Australia, were ordinated. The mean direction of the vectors between…”
    Get full text
    Journal Article
  13. 13

    Randomized comparison of the safety of Flublok® versus licensed inactivated influenza vaccine in healthy, medically stable adults ≥50 years of age by Izikson, Ruvim, Leffell, David J, Bock, S. Allan, Patriarca, Peter A, Post, Penny, Dunkle, Lisa M, Cox, Manon M.J

    Published in Vaccine (27-11-2015)
    “…Abstract Background The safety and tolerability of Flublok® , a purified recombinant hemagglutinin seasonal influenza vaccine, was compared to AFLURIA® in a…”
    Get full text
    Journal Article
  14. 14

    Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells by Meghrous, Jamal, Khramtsov, Nikolai, Buckland, Barry C., Cox, Manon M.J., Palomares, Laura A., Srivastava, Indresh K.

    Published in Biotechnology and bioengineering (01-11-2015)
    “…ABSTRACT Dissolved carbon dioxide (dCO2) accumulation during cell culture has been recognized as an important parameter that needs to be controlled for…”
    Get full text
    Journal Article
  15. 15

    Improved stability of recombinant hemagglutinin using a formulation containing sodium thioglycolate by Rhodes, David G, Holtz, Kathy, Robinson, Pam, Wang, Keyang, McPherson, Clifton E, Cox, Manon M.J, Srivastava, Indresh K

    Published in Vaccine (04-11-2015)
    “…Abstract This study was designed to improve the stability of liquid formulations of recombinant influenza hemagglutinin (rHA) and to understand the mechanism…”
    Get full text
    Journal Article
  16. 16
  17. 17

    An experimental methodology to characterise post-necking behaviour and quantify ductile damage accumulation in isotropic materials by Sancho, A., Cox, M.J., Cartwright, T., Davies, C.M., Hooper, P.A., Dear, J.P.

    “…The development of ductile damage, that occurs beyond the point of necking in a tensile test, can be difficult to quantify. An experimental methodology has…”
    Get full text
    Journal Article
  18. 18

    Innovations in vaccine development: can regulatory authorities keep up? by Cox, Manon M J, Onraedt, Annelies

    Published in Expert review of vaccines (01-10-2012)
    “…Vaccine Production Summit San Francisco, CA, USA, 4-6 June 2012 IBC's 3rd Vaccine Production Summit featured 28 presentations discussing regulatory challenges…”
    Get more information
    Journal Article
  19. 19

    Uniaxial compression of single crystal and polycrystalline tantalum by Whiteman, G., Case, S., Millett, J.C.F., Cox, M.J., Avraam, P., Dear, J.P., Sancho, A., Hooper, P.A.

    “…A series of compression experiments characterising the elastic-plastic response of single crystal and polycrystalline tantalum from quasi-static to…”
    Get full text
    Journal Article
  20. 20

    Evaluation of the Virus Counter ® for rapid baculovirus quantitation by Ferris, Matthew M., Stepp, Patricia C., Ranno, Kirk A., Mahmoud, Wafaa, Ibbitson, Elizabeth, Jarvis, James, Cox, Manon M.J., Christensen, Kurt, Votaw, Heather, Edwards, Dean P., Rowlen, Kathy L.

    Published in Journal of virological methods (01-01-2011)
    “…The utility of a new instrument for rapid virus quantitation, the Virus Counter, was evaluated in a blind study conducted at three sites. This instrument is a…”
    Get full text
    Journal Article